VC  Camford Capital

https://www.camford.vc/





     Office Locations:

435 Tasso St
Palo Alto, CA 94301

 

Stages:

  • Early


 

Industries:

  • Consumer Products & Services
  • Financial Services
  • Life Sciences & Healthcare

  •  

    Description:

    Camford Capital is a venture capital firm based in Palo Alto, California. The firm invests in Enterprise, Consumer, FinTech, and Healthcare companies in the US, Europe, and Asia. The team brings decades of combined experience in entrepreneurship, operations, investment, and research.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Ali Farahanchi Partner
    Andrew Gu Partner
    Judy Yan Partner
    Kevin Ding Partner
    Poorya Hosseini Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      12/15/2023


      Totus Medicines


      CA


      $66,000,000


      Series B


      07/20/2023


      SURGE Therapeutics


      MA


      $32,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: